Trials / Completed
CompletedNCT07125014
Frequency and Predictors of Post-ERCP Pancreatitis in a South Asian Tertiary Care Center
Frequency and Risk Factors of Post-ERCP Pancreatitis: A Single-Center Experience From South Asia
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- Nangarhar University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study was conducted at the Department of Gastroenterology, Lady Reading Hospital, Peshawar, Pakistan, from January 2023 to December 2023. It aimed to determine how often patients develop pancreatitis (inflammation of the pancreas) after undergoing a procedure called endoscopic retrograde cholangiopancreatography (ERCP), and to identify the main factors that increase this risk. We reviewed the medical records of 300 adult patients who had ERCP for various conditions, such as bile duct stones, tumors, and strictures. We assessed patient characteristics, procedure details, and laboratory results to see which factors were linked to post-ERCP pancreatitis. The study found that prolonged cannulation time, injection of contrast into the pancreatic duct, and high levels of C-reactive protein before the procedure were the strongest predictors of this complication. These findings may help doctors identify high-risk patients and take preventive steps to reduce the chances of pancreatitis after ERCP.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Observational study | This is an observational study with no experimental or therapeutic interventions administered to participants. All data were collected retrospectively from existing hospital records for patients who underwent ERCP between January 2023 and December 2023 at Lady Reading Hospital, Peshawar. No drugs, devices, or procedures were assigned to participants as part of this research. |
Timeline
- Start date
- 2023-01-01
- Primary completion
- 2023-12-14
- Completion
- 2023-12-31
- First posted
- 2025-08-15
- Last updated
- 2025-08-15
Locations
1 site across 1 country: Pakistan
Source: ClinicalTrials.gov record NCT07125014. Inclusion in this directory is not an endorsement.